Work

Safety of FEIBA and emicizumab (SAFE): Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients on emicizumab

Year: 2022

Type: article

Source: Haemophilia

DOI: 10.1111/hae.14684

Authors: Hande Kizilocak, Elizabeth Marquez‐Casas, Jemily Malvar, Guy Young

Institutions: Children's Hospital Los Angeles, University of Southern California

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Takeda Pharmaceutical Company

Award: G5473145961

OpenAlex ID: W4307340608

FWCI: 2.509

Cites: 11

Cited by: 20

Related to: 10